← Evidence map

ArticleBiomedicines2026

Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis.

Xavier Adhoute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis. | OpenQuestion